Vincerx Pharma

About:

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

Website: https://vincerx.com/

Description:

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation antibody-drug conjugate platform.

Total Funding Amount:

$16.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2018-01-01

Founders:

Ahmed M. Hamdy, Raquel Izumi

Number of Employees:

11-50

Last Funding Date:

2024-04-25

IPO Status:

Public

Industries:

© 2025 bioDAO.ai